FITFOOD: The Effect of a Combined Personalized Nutritional Intervention and a Personalized Graded Activity Functional Training Program on Physical Performance in Hospitalized Patients, Compared to Usual Care

Sponsor
Radboud University Medical Center (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05413616
Collaborator
(none)
136
1
2
24
5.7

Study Details

Study Description

Brief Summary

This project aims to improve physical performance in older patients who are at risk for sarcopenia, by offering a personalized combined nutritional intervention with a physical activity training program. The intervention starts at hospital admittance and is continued after discharge in the home care setting, supported by an e-health application.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: FITFOOD lifestyle intervention
N/A

Detailed Description

Rationale: The older hospitalized population (≥65 year) is growing and specifically at risk for developing sarcopenia, which results in decreased muscle mass and physical functioning and has a negative influence on activities of daily living, independence, quality of life, re-admissions, and nursing home placement. Current knowledge shows that a physical activity training programs consisting of tailored resistance and endurance exercise can improve muscle mass in healthy elderly. Nutritional interventions in conjunction with physical activity based on individual protein requirements, high quality protein and timing of protein intake can further stimulate muscle protein synthesis. The effect of a combined nutritional intervention with physical activity in healthy individuals and athletes has been studied before, but not in older hospitalized patients at risk for sarcopenia. A personalized combined physical activity program and a nutritional intervention for patients at risk for sarcopenia could be a solution and is an exciting emerging field of research with the potential to dramatically improve patient outcomes. The average hospital admittance is 4 to 5 days in which the prevention of the decline in muscle mass and physical performance can be initiated but not improved. Thus, the translation of a prolonged combined intervention to home care is essential. To support the combined personalized nutritional intervention and physical exercise intervention during hospitalization and home care, an eHealth application for and with older patients at risk for sarcopenia can be beneficial.

Objective: This project aims to improve physical performance in older patients who are at risk for sarcopenia, by offering a personalized combined nutritional intervention with a physical activity training program. The intervention starts at hospital admittance and is continued after discharge in the home care setting, supported by an e-health application.

Study design: The study will be performed as a randomized clinical trial. Study population:

The study population hospitalized adult patients of ≥65 years, living in the municipal of Nijmegen (PO box 6500-6546) at risk for sarcopenia according to SARC-F within the Radboud University Medical Centre.

Intervention: One group receives a personalized nutritional intervention by a dietician combined with a functional training program by physical therapists. The nutritional intervention focuses on adequate protein intake, type, and timing of protein. The exercise program will make use of goal setting throughout the intervention period to optimize the training effect. The control group will receive usual care.

Study parameters: The primary study outcome is based on the difference in change in physical performance between baseline and after 12 weeks of intervention of the intervention and the control group (usual care). This will be measured using the Timed Up and Go test, a sensitive tool to measure physical performance in elderly. Timed Up and Go data will be analyzed using regression analysis of covariance (ANCOVA). As secondary outcomes, the effect on short physical performance battery (gait speed, chair stand and balance test), muscle strength, muscle mass, nutritional status, movement, independence, quality of life, clinical outcomes and cost-effectiveness will be studied.

Nature and extent of the burden and risks associated with participation, benefit, and group relatedness: Study measurements are non-invasive. This study will not confer any no additional risks. The intervention will start at hospital admittance and will be continued after discharge in the home setting by a dietician and physiotherapist in their nearby home, which keeps the burden for the patient relatively low and is an extra service for the patient.

Protein supplementation will be delivered within the save amounts. Possible serious reactions to the intervention will be noted as SAE's.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
136 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Effect of a Combined Personalized Nutritional Intervention and a Personalized Graded Activity Functional Training Program on Physical Performance in Hospitalized Patients, Compared to Usual Care: A Randomized Clinical Trial
Anticipated Study Start Date :
Jul 1, 2022
Anticipated Primary Completion Date :
Jul 1, 2024
Anticipated Study Completion Date :
Jul 1, 2024

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Standard care

Experimental: FITFOOD lifestyle intervention

Lifestyle intervention consisting of both a nutritional and exercise intervention.

Behavioral: FITFOOD lifestyle intervention
Lifestyle intervention with a nutritional and exercise component.

Outcome Measures

Primary Outcome Measures

  1. Change in Timed Up & Go [Baseline, 1 day before hospital release, 4 weeks after baseline, 12 weeks after baseline, 24 weeks after baseline.]

    TUG

Secondary Outcome Measures

  1. Change in Short Physical Performance Battery [Baseline, 1 day before hospital release, 4 weeks after baseline, 12 weeks after baseline, 24 weeks after baseline.]

    Short Physical Performance Battery (scale: 0-12, a high score indicates no disability, a low score means disabilities may be present or developing).

  2. Change in muscle strength [Baseline, 1 day before hospital release, 12 weeks after baseline, 24 weeks after baseline.]

    Handgrip strength

  3. Change in muscle mass [Baseline, 1 day before hospital release, 12 weeks after baseline, 24 weeks after baseline.]

    BIA

  4. Change in nutritional status [Baseline, 1 day before hospital release, 4 weeks after baseline, 12 weeks after baseline, 24 weeks after baseline.]

    Patient-Generated Subjective Global Assessment (PG-SGA). Scale: 0-49 (low score: no intervention needed. Score>9: serious indication for intervention)

  5. Change in nutritional intake (energy, protein, fluid, fiber, vitamin D, magnesium, selenium, omega-3 fatty acids). [Baseline, 1 day before hospital release, 4 weeks after baseline, 12 weeks after baseline, 24 weeks after baseline.]

    Food diary.

  6. Change in movement according to actometer [Baseline, 1 day before hospital release, 12 weeks after baseline, 24 weeks after baseline.]

    Activ8 measurement will assess movement during 1 week for each measurement point

  7. Change in activities of daily living [Baseline, 1 day before hospital release, 12 weeks after baseline, 24 weeks after baseline.]

    LLFDI-CAT (Late-Life Function and Disability Instrument Computer Adaptive Test). LLFDI-CAT scores are transformed to a scale with mean = 50 and standard deviation =10. Lower scores correspond to more limitation.

  8. Change in quality of life [Baseline, 1 day before hospital release, 12 weeks after baseline, 24 weeks after baseline.]

    EQ-5D-5L (EuroQol 5-level five-dimensional questionnaire). Scores 1-5 where 1 is good and 5 indicates issues or problems.

  9. Clinical outcomes [24 weeks after baseline]

    Length of hospital stay

  10. Clinical outcomes [24 weeks after baseline]

    Re-admission

  11. Clinical outcomes [24 weeks after baseline]

    Complications

  12. Clinical outcomes [24 weeks after baseline]

    Mortality

  13. Medical consumption [Baseline]

    iMCQ: iMTA Medical Consumption Questionnaire. Medical consumption will be measured using iMCQ and costs are calculated using Dutch reference values.

  14. Medical consumption [12 weeks after baseline]

    iMCQ: iMTA Medical Consumption Questionnaire. Medical consumption will be measured using iMCQ and costs are calculated using Dutch reference values.

  15. Medical consumption [24 weeks after baseline]

    iMCQ: iMTA Medical Consumption Questionnaire. Medical consumption will be measured using iMCQ and costs are calculated using Dutch reference values.

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Aged ≥65 years

  • Living within the municipal of Nijmegen (PO box 6500-6546)

  • Risk for sarcopenia according to SARC-F

  • Minimal length of stay of 48 hours on one of the following hospital wards: Cardiology, Cardio-Thoracic Surgery, Internal Medicine, Lung Disease and Urology of the Radboudumc

  • Understanding and speaking of the Dutch language

  • Mentally competent

  • Signed informed consent

Exclusion Criteria:
  • Complete use of tube feeding or parenteral nutrition

  • Renal insufficiency (MDRD-GFR < 60ml/min and/or proteinuria)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Sabien van Exter Nijmegen Gelderland Netherlands 6531DK

Sponsors and Collaborators

  • Radboud University Medical Center

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Radboud University Medical Center
ClinicalTrials.gov Identifier:
NCT05413616
Other Study ID Numbers:
  • 2020-6664
First Posted:
Jun 10, 2022
Last Update Posted:
Jun 21, 2022
Last Verified:
May 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Radboud University Medical Center
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 21, 2022